Nifty

:

26177.15

Sensex

:

85524.84

4.75 (0.02%)
-42.64 (-0.05%)

Login

Nifty
Sensex

:
:

26177.15
85524.84

4.75 (0.02%)
-42.64 (-0.05%)

Anuh Pharma Ltd.

Pharmaceuticals & Drugs - API

Rating :

59/99

BSE: 506260 | NSE: ANUHPHR

Watchlist

NSE BSE

78.08

22-Dec-2025

Open
High
Low
Previous Close

79.26
79.47
77.4
78.35

Volume
Traded Value (lacs)
52 Week High
52 Week Low

24317
1914559.92
121.5
74.25

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

782.05
20.20
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

779.89
0.96%
2.39

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

7.33
8.90
7.84

EBITDA CAGR (%)

10 Years
5 Years
3 Years

5.06
6.40
3.50

PAT CAGR (%)

10 Years
5 Years
3 Years

6.26
10.73
9.38

P:E (Median)

8 Years
5 Years
3 Years

18.90
18.63
17.83

P:BV (Average)

8 Years
5 Years
3 Years

2.95
2.86
2.93

EV:EBITDA (Average)

8 Years
5 Years
3 Years

12.23
11.64
11.60

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 185.88 165.95 12.01% 186.48 137.91 35.22% 198.14 163.89 20.90% 159.51 172.10 -7.32%
Expenses 174.00 149.07 16.72% 176.19 127.34 38.36% 179.47 144.67 24.05% 144.72 148.11 -2.29%
EBITDA 11.88 16.88 -29.62% 10.29 10.57 -2.65% 18.67 19.22 -2.86% 14.79 23.99 -38.35%
EBIDTM 6.39% 10.17% 5.52% 7.66% 9.42% 11.73% 9.27% 13.94%
Other Income 0.98 3.40 -71.18% 3.39 3.72 -8.87% 1.40 2.82 -50.35% 0.94 3.66 -74.32%
Interest 0.08 0.16 -50.00% 0.21 0.14 50.00% 0.03 0.10 -70.00% 0.28 0.14 100.00%
Depreciation 2.86 1.92 48.96% 2.51 1.88 33.51% 2.76 2.23 23.77% 2.18 2.20 -0.91%
PBT 9.92 18.19 -45.46% 10.95 12.27 -10.76% 17.28 19.72 -12.37% 13.27 25.30 -47.55%
Tax 2.31 3.15 -26.67% 2.65 2.76 -3.99% 4.82 4.36 10.55% 2.92 6.19 -52.83%
PAT 7.61 15.04 -49.40% 8.30 9.51 -12.72% 12.46 15.36 -18.88% 10.34 19.11 -45.89%
PATM 4.09% 9.06% 4.45% 6.89% 6.29% 9.37% 6.48% 11.11%
EPS 0.76 1.50 -49.33% 0.83 0.95 -12.63% 1.24 1.53 -18.95% 1.03 1.91 -46.07%

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 730.01 661.51 647.00 527.49 486.65 431.96 306.96 320.66 238.09 206.15 326.22 Net Sales Growth 14.09% 2.24% 22.66% 8.39% 12.66% 40.72% -4.27% 34.68% 15.49% -36.81% Cost Of Goods Sold 566.09 496.25 483.70 399.11 375.48 327.60 228.64 241.48 179.59 149.43 247.00 Gross Profit 163.92 165.26 163.31 128.38 111.16 104.36 78.32 79.19 58.50 56.72 79.23 GP Margin 22.45% 24.98% 25.24% 24.34% 22.84% 24.16% 25.51% 24.70% 24.57% 27.51% 24.29% Total Expenditure 674.38 599.98 571.25 475.68 439.18 386.84 283.73 290.70 219.77 183.46 288.67 Power & Fuel Cost - 12.35 12.37 11.02 8.80 8.66 6.31 4.79 4.09 3.07 3.48 % Of Sales - 1.87% 1.91% 2.09% 1.81% 2.00% 2.06% 1.49% 1.72% 1.49% 1.07% Employee Cost - 23.04 19.39 17.15 15.10 14.29 13.36 10.14 8.90 7.22 6.58 % Of Sales - 3.48% 3.00% 3.25% 3.10% 3.31% 4.35% 3.16% 3.74% 3.50% 2.02% Manufacturing Exp. - 33.87 29.06 23.90 18.30 16.76 14.44 15.03 11.82 12.93 14.54 % Of Sales - 5.12% 4.49% 4.53% 3.76% 3.88% 4.70% 4.69% 4.96% 6.27% 4.46% General & Admin Exp. - 4.26 3.49 2.73 2.25 2.42 1.87 2.45 1.92 1.69 2.03 % Of Sales - 0.64% 0.54% 0.52% 0.46% 0.56% 0.61% 0.76% 0.81% 0.82% 0.62% Selling & Distn. Exp. - 11.38 9.63 9.01 8.63 7.60 6.08 6.61 5.95 5.11 8.25 % Of Sales - 1.72% 1.49% 1.71% 1.77% 1.76% 1.98% 2.06% 2.50% 2.48% 2.53% Miscellaneous Exp. - 18.84 13.61 12.77 10.62 9.51 13.02 10.21 7.49 4.03 8.25 % Of Sales - 2.85% 2.10% 2.42% 2.18% 2.20% 4.24% 3.18% 3.15% 1.95% 2.08% EBITDA 55.63 61.53 75.75 51.81 47.47 45.12 23.23 29.96 18.32 22.69 37.55 EBITDA Margin 7.62% 9.30% 11.71% 9.82% 9.75% 10.45% 7.57% 9.34% 7.69% 11.01% 11.51% Other Income 6.71 9.46 12.10 6.11 5.20 10.54 4.21 4.70 7.38 7.59 3.51 Interest 0.60 1.24 0.96 0.75 1.58 2.03 1.26 0.60 0.45 0.72 0.86 Depreciation 10.31 8.74 8.58 9.70 11.96 15.08 7.03 1.66 1.83 1.97 2.26 PBT 51.42 61.01 78.31 47.47 39.12 38.55 19.16 32.40 23.42 27.59 37.94 Tax 12.70 13.65 18.25 11.29 8.56 10.12 4.85 9.04 6.90 7.54 12.13 Tax Rate 24.70% 22.37% 23.30% 23.78% 21.88% 26.25% 25.31% 27.90% 29.46% 27.33% 31.97% PAT 38.71 47.35 60.06 36.18 30.56 28.44 14.31 23.37 16.51 20.05 25.80 PAT before Minority Interest 38.71 47.35 60.06 36.18 30.56 28.44 14.31 23.37 16.51 20.05 25.80 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 5.30% 7.16% 9.28% 6.86% 6.28% 6.58% 4.66% 7.29% 6.93% 9.73% 7.91% PAT Growth -34.41% -21.16% 66.00% 18.39% 7.45% 98.74% -38.77% 41.55% -17.66% -22.29% EPS 3.86 4.73 5.99 3.61 3.05 2.84 1.43 2.33 1.65 2.00 2.57

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 326.02 291.22 241.22 213.77 190.64 162.21 164.60 149.62 140.55 119.28 Share Capital 25.06 25.06 25.06 25.06 25.06 12.53 12.53 12.53 12.53 12.53 Total Reserves 300.97 266.16 216.17 188.72 165.59 149.68 152.07 137.09 128.02 106.75 Non-Current Liabilities 0.01 1.35 1.66 2.50 2.53 1.46 -0.04 -0.20 -0.49 -0.35 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 2.03 1.38 1.58 1.54 1.51 1.17 0.87 0.95 0.73 0.78 Current Liabilities 178.51 152.69 161.34 130.91 139.47 162.71 74.80 58.63 47.42 72.48 Trade Payables 156.84 140.50 152.77 121.57 120.02 104.64 58.92 51.98 42.18 52.32 Other Current Liabilities 10.46 10.04 8.50 6.16 5.76 13.31 11.19 2.91 4.05 2.72 Short Term Borrowings 10.50 2.01 0.00 3.11 13.60 44.56 4.39 2.44 0.00 2.11 Short Term Provisions 0.71 0.14 0.07 0.06 0.10 0.20 0.31 1.30 1.19 15.33 Total Liabilities 504.54 445.26 404.22 347.18 332.64 326.38 239.36 208.05 187.48 191.41 Net Block 58.21 48.95 52.81 61.42 71.42 84.04 21.17 16.70 17.33 18.32 Gross Block 119.99 104.15 99.91 99.67 97.93 95.67 26.51 20.48 19.28 33.42 Accumulated Depreciation 61.78 55.20 47.10 38.25 26.51 11.62 5.34 3.78 1.95 15.11 Non Current Assets 128.38 106.72 96.60 88.49 94.91 103.42 87.19 53.87 49.52 40.37 Capital Work in Progress 0.27 0.45 0.00 0.10 0.00 0.00 33.85 5.92 0.26 0.19 Non Current Investment 51.95 41.71 39.68 21.21 20.37 13.70 30.03 30.70 31.13 21.03 Long Term Loans & Adv. 2.64 1.31 4.11 2.20 2.62 2.68 2.13 0.56 0.80 0.84 Other Non Current Assets 15.30 14.30 0.00 3.55 0.50 3.00 0.00 0.00 0.00 0.00 Current Assets 376.17 338.54 307.61 258.69 237.73 222.95 152.18 154.18 137.96 151.04 Current Investments 53.86 55.05 51.15 21.47 11.01 65.86 8.62 35.56 39.26 21.95 Inventories 74.48 75.40 72.64 79.92 81.43 61.49 42.85 31.90 29.82 23.69 Sundry Debtors 215.87 189.95 171.23 135.71 106.86 81.03 74.53 70.92 56.65 74.67 Cash & Bank 19.74 8.37 6.65 15.95 20.09 2.52 11.49 8.00 6.39 13.38 Other Current Assets 12.23 0.97 0.67 1.00 18.33 12.05 14.69 7.78 5.85 17.35 Short Term Loans & Adv. 10.17 8.78 5.27 4.63 1.53 4.73 3.43 1.06 3.90 15.34 Net Current Assets 197.66 185.84 146.28 127.78 98.26 60.25 77.38 95.55 90.55 78.55 Total Assets 504.55 445.26 404.21 347.18 332.64 326.37 239.37 208.05 187.48 191.41

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 37.12 12.93 53.90 28.86 -18.73 48.93 7.12 1.83 26.12 16.50 PBT 61.01 78.31 47.47 39.12 38.55 19.16 32.40 23.42 27.59 37.94 Adjustment 0.30 -2.73 3.53 8.17 7.43 8.30 -2.12 -1.88 -4.82 -0.74 Changes in Working Capital -13.06 -43.58 16.37 -9.29 -54.98 26.57 -13.40 -12.57 11.09 -7.96 Cash after chg. in Working capital 48.25 32.00 67.37 38.00 -9.00 54.03 16.89 8.96 33.86 29.23 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -11.12 -19.07 -13.47 -9.14 -9.73 -5.09 -9.76 -7.13 -7.73 -12.74 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -19.91 0.92 -43.48 -7.82 52.20 -76.53 2.86 1.89 -20.31 -5.24 Net Fixed Assets -15.66 -4.69 -0.14 -1.84 -2.26 -35.31 -33.96 -6.86 14.07 -10.66 Net Investments -9.05 -5.93 -48.15 -11.30 48.18 -40.91 27.61 4.13 -27.41 -0.38 Others 4.80 11.54 4.81 5.32 6.28 -0.31 9.21 4.62 -6.97 5.80 Cash from Financing Activity -4.86 -8.57 -12.29 -19.45 -33.12 22.17 -6.51 -5.12 -3.66 -9.00 Net Cash Inflow / Outflow 12.36 5.27 -1.87 1.60 0.35 -5.43 3.47 -1.40 2.15 2.25 Opening Cash & Equivalents 7.20 1.93 3.80 2.20 1.85 7.27 3.80 5.20 3.05 0.80 Closing Cash & Equivalent 19.56 7.20 1.93 3.80 2.20 1.85 7.27 3.80 5.20 3.05

Financial Ratios

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 32.53 29.06 48.14 42.66 38.04 32.37 32.85 29.86 28.05 23.80 ROA 9.97% 14.14% 9.63% 8.99% 8.63% 5.06% 10.44% 8.35% 10.58% 14.37% ROE 15.34% 22.56% 15.90% 15.11% 16.12% 8.75% 14.87% 11.38% 15.43% 23.44% ROCE 19.77% 29.66% 21.05% 19.33% 19.75% 10.87% 20.56% 16.31% 21.61% 34.91% Fixed Asset Turnover 5.95 6.37 5.31 4.97 4.55 5.20 13.71 12.23 8.23 12.19 Receivable days 111.12 101.36 105.71 90.17 77.87 89.32 82.39 95.73 110.46 76.28 Inventory Days 41.04 41.55 52.54 59.98 59.23 59.91 42.34 46.32 45.01 21.42 Payable days 109.35 110.65 125.45 117.42 125.15 102.62 71.01 80.06 97.41 64.25 Cash Conversion Cycle 42.81 32.26 32.80 32.72 11.94 46.61 53.72 61.99 58.06 33.45 Total Debt/Equity 0.03 0.01 0.00 0.01 0.07 0.27 0.03 0.02 0.00 0.02 Interest Cover 50.10 82.82 64.61 25.76 19.99 16.23 55.16 52.91 39.30 44.87

Top Investors:

investor education and protection fund (iepf)

Annual Reports:

News Update:

Anuh Pharma gets CEP for Sulfadimethoxine from EDQM
5th Dec 2025, 15:12 PM

This approval reinforces Anuh Pharma’s commitment to delivering high-quality Active Pharmaceutical Ingredients that adhere to the most stringent global regulatory standards
Read More
Anuh Pharma - Quarterly Results
8th Nov 2025, 00:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback